ArticlePDF Available

Scales to measure dimensions of hallucinations and delusions: The psychotic symptom rating scales (PSYRATS)

Authors:

Abstract

Scales to measure the severity of different dimensions of auditory hallucinations and delusions are few. Biochemical and psychological treatments target dimensions of symptoms and valid and reliable measures are necessary to measure these. The inter-rater reliability and validity of the Psychotic Symptom Rating Scales (PSYRATS: auditory hallucination subscale and delusions subscale), which measure several dimensions of auditory hallucinations and delusions were examined in this study. The two scales were found to have excellent inter-rater reliability. Their validity as compared with the KGV scale (Krawiecka et al. 1977) was explored. It is concluded that the PSYRATS are useful assessment instruments and can complement existing measures.
,n
QUALITY OF LIFE IN SCHIZOPHRENIA:
SYMPTOM, INSIGHT AND
NEUROPSYCHOLOGICAL
DETERMINANTS
Ma
rianne
S.
Goodman,
Thomas
E.
Smith,
James
W.
Hull
,
Tracy
E.
Felger
,
Andiea
Hedayat-Harris,
Catherine
A.
Walsh,
Susan
C.
Raymond,
Kim
A. Weiss
Department
of
Psychiatry. Cornell University
Med
ical College.
White Plains.
NY
10605. USA
The theoretical construct
of
quality of life has become an
important outcome measure in mental health. Recently, several
measures have been developed that are applicable to the
chronically
mental1y
i1l
and have been utilized in schizophrenic
populations. Early assessments of quality of lifefound associa-
tions with symptoms, especiallydepression and social circum-
stances. There has been no study which correlates quality
of
life with psychotic symptoms, insight, and neuropsychological
variables. In this study, schizophrenic patients recently dis-
charged from the hospital and recovering from a relapse were
assessed with the SAPS, SANS, a neuropsychological battery
testing attention, memory and executive functioning, and the
Scale for Assessment of Unawareness of Mental Disorder
(SUMD). Quality of life was measured using the Lehman
Quality
of
Life Interview (QOL). In preliminary analyses of 17
subjects, QOL was associated with positive symptoms and
rnisattribution on the SUMD (correlations
of
0.4-0.7). No
significantcorrelations were noted between neuropsychological
deficits and QOL. Further understanding of the relationship
between these variables may offer strategies for improving the
quality of life of individuals with schizophrenia.
"~4
INTENSIVE COGNITIVE-BEHAVIOURAL
THERAPY
FOR
RECENT ONSET
SCHIZOPHRENIA: A PILOT STUDY
G.
Haddock,
R.
Hopkins,
N.
Tarrier,
T.
Morrison,
S. Lewis
School
of
Psychiatry and the Behavioural Sciences, University
of
Manchester
M208LR.
UK
The use of Cognitive-Behavioural Therapy (CBT) with
schizophrenic patients whohave persistent psychotic symptoms,
such as hallucinations and delusions, has been shown to
be
beneficialin terms of reducing the occurrence of symptoms and
the distress and disruption caused by them. Most research has
been carried out with patients experiencing chronic medication
resistant symptoms. However CBT applied early in the illness
may be more effectiveat reducing symptoms which have had
lessopportunity to becomesystematised into patient's livesand
research in this area has become a recent focus of interest.
We have completed a pilot study which examined the effec-
tiveness
of
intensive CBT, compared to supportive counselling,
for patients experiencing recent onset psychotic symptoms.
223
Patients were randomly allocated to treatment groups and
received 3 sessions of therapy per week for 5 weeks or until
discharge (whichever was the shorter). Following discharge,
four monthly booster sessions were offered. All patients had a
discharge diagnosis of DSM-IV schizophrenia, schizoalTective
disorder or schizophreniform disorder. Results indicate that
CBT is applicable for patients experiencing recent onset acute
psychotic symptoms in conjunction with neuroleptic medica-
tion. A multicentre Randomised Control Trial is now underway
to examine further the effectiveness of
CBT in this patient
group.
"J{
THE
DEPENDENCE ON FINANCIAL
SUPPORT
FROM
SOCIAL AGENCIES
EARLY IN
THE
COURSE OF
SCHIZOPHRENIA
Beng-Choon
Ho,
MD,
Michael
Flaum,
MD,
Nancy
Andreasen,
MD,
PhD
Mental Health Clinical Research Center. The University
of
Iowa. College
of
Medicine. Department
of
Psychiatry. Iowa
City, IA 52242. USA
Objective: It is clear that many, if not most, patients with
schizophrenia will require external financial support at some
time during their illness.Wesought to determine ifthey become
dependent upon such support early in the course of the illness.
Method:
48 patients were followed for at least 2 years after
their first hospitalization for schizophrenia (Mean duration of
fol1ow-up=6l months,
SD-23
.S). Sources of primary and
secondary income were recorded.
Results: At the time of first hospitalization, 7 (14.6%) were
already receiving financial assistance from a social agency. A
year later, this number rose to
29 (60.4%), while only 15
(31.3%) of the sample were self-supporting. Further analyses
demonstrate that the percent of patients requiring such support
increases gradually thereafter. The mean time period at which
these patients first became financially dependent on
a social
agency during the
follow-up was 9.2 months after the initial
hospitalization. Once they have begun receiving such support,
all patients except one remained so at their latest follow-up.
Conclusion:
Among patients hospitalized for schizophrenia,
the majority are financiallysupported by a social serviceagency
within the first year of their initial hospitalization and continue
to remain so thereafter.
b3b
DETERMINING
THE
TRUE
COSTS OF
BED-AND-BOARD
FOR
THE
SERIOUSLY
MENTALLY ILL.
1. PSYCHIATRIC
HOSPITALS
Gilbert
Honigfeld,
Ph.D.
Room D-317. Department
of
Psychiatry. Robert Wood Johnson
Medical School, Piscataway, New Jersey 08855. USA
How much is spent in the US on bed-and-board for individ-
uals with schizophrenia and other serious mental illnesses?This
... one such critique is that the multidimensional nature of symptoms such as hallucinations and delusions are not fully represented [12]. the psychotic Symptom rating Scales (pSYrAtS) [13] may contribute to more thorough assessment of psychotic symptoms. the instrument consists of two subscales measuring auditory hallucinations (the auditory hallucinations subscale, AHS) and delusions (the delusions subscale, DS). ...
... DS has six items that assess amount and duration of preoccupation of delusions, level of conviction, amount and intensity of distress, as well as disruption to life caused by these beliefs. All items are rated from 0 to 4, with higher scores indicating more symptoms/higher symptom related distress [13,21]. ...
Article
Purpose: The Positive and Negative Syndrome Scale (PANSS) is one of the most commonly used assessment tools for measuring psychotic symptoms. The Psychotic Symptom Rating Scales (PSYRATS) is another instrument created specifically to assess delusions and auditory hallucinations. However, research on the concurrent validity of PSYRATS with PANSS is limited. There are also inconsistent findings regarding the association between the PSYRATS scales and the PANSS positive scale. The present study aims to add to the understanding of the concurrent validity of these measures, while also incorporating a broader measure of psychiatric symptoms (the symptom scale from the Global Assessment of Functioning Scale – split version, GAF-S). Materials and Methods: Spearman’s Rank Order Correlations (rho) were calculated for scores from the PANSS positive scale, PSYRATS and GAF-S in a sample of 148 participants with psychotic disorders at three time points. Results: The findings indicate concurrent validity between PSYRATS and PANSS, while the PSYRATS scales were not consistently correlated with GAF-S. Conclusions: PSYRATS may be a valid assessment tool for evaluating psychotic symptoms. The utility of PSYRATS in research and clinical practice should be investigated further.
... Sociodemographic data were collected during the baseline evaluation. Moreover, during each evaluation, auditory hallucinations were assessed using the auditory hallucinations subscale of the Psychotic Symptom Rating Scales (PSYRATS-AH) [40]. The auditory hallucinations subscale comprises 11 Likert-type items. ...
... The auditory hallucinations subscale comprises 11 Likert-type items. The PSYRATS was demonstrated to be a reliable instrument for measuring different aspects associated with auditory hallucinations [40]. In the present study, the PSYRATS-AH total score, as well as the following subscales were used for statistical analyses: frequency, distress, attribution, and loudness [41]. ...
Article
Full-text available
Avatar therapy (AT) is a novel virtual reality-based psychotherapy that has been developed to treat auditory verbal hallucinations (AVH) in treatment-resistant schizophrenia. Various psychotherapeutic components, such as emotions and sense of presence, could contribute to clinical outcomes. However, the interplay between sense of presence, emotions, and clinical response has seldom been investigated. This study aimed to explore the relations between sense of presence, emotions, and clinical outcomes in AT. To conduct this investigation, data from previous and ongoing AT trials were used. Sense of presence and emotions were assessed using standardized questionnaires. AVH were evaluated using the Psychotic Symptom Rating Scales. While sense of presence was positively associated with positive emotions such as control and serenity, no significant associations were found for negative emotions. Moreover, a higher level of sense of presence was associated with a bigger decrease in AVH. Overall, positive emotions seem to be associated with sense of presence in AT. Sense of presence also seems to be involved in the therapeutic outcome, thereby suggesting that this could be an important component related to clinical response. More studies are needed to confirm these trends, which could be generalized to other virtual reality-based psychotherapies.
... Sociodemographic data was collected during the baseline evaluation. Moreover, during each evaluation, auditory hallucinations were assessed using the auditory hallucinations subscale of the Psychotic Symptom Rating Scales (PSYRATS-AH) [35]. The auditory hallucinations subscale comprises 11 Likert-type items. ...
... The auditory hallucinations subscale comprises 11 Likert-type items. The PSYRATS was demonstrated to be a reliable instrument to measure different aspects associated with auditory hallucinations [35]. In the present study, the PSYRATS-AH total score, as well as the following subscales were used for statistical analyses: frequency, distress, attribution, and loudness [36]. ...
Preprint
Full-text available
Avatar therapy (AT) is a novel virtual reality-based psychotherapy that has been developed to treat auditory verbal hallucinations (AVH) in treatment-resistant schizophrenia patients. Various psychotherapeutic components, such as emotions and sense of presence, could contribute to clinical outcomes. However, the interplay between sense of presence, emotions and clinical response has seldom been investigated. This study aimed to explore the relations between sense of presence, emotions, and clinical outcomes in AT. To conduct this investigation, data from previous and ongoing AT trials were used. Sense of presence and emotions were assessed using standardized questionnaires. AVH were evaluated using the Psychotic Symptom Rating Scales. While sense of presence was positively associated with positive emotions such as control and serenity, no significant associations were found for negative emotions. Moreover, a higher level of sense of presence was associated with a bigger decrease in AVH. Overall, positive emotions seem to be associated with sense of presence in AT. Sense of presence also seems to be involved in the therapeutic outcome, thereby suggesting that this could be an important component related to clinical response. More studies are needed to confirm these trends, which could be generalized to other virtual reality-based psychotherapies.
... Sociodemographic information and medication use were collected using a self-report questionnaire. Additional baseline data were collected using quantitative measures covering: severity of psychotic symptoms (CAARMS, 2 the Positive and Negative Syndrome Scale (PANSS) negative scale, 30 the Psychotic Symptom Rating Scale (PSYRATS), 31 Community Assessment of Psychic Experiences-42 (CAPE-42 32 ), depression (Patient Health Questionniare-9 (PHQ-9 33 )) and anxiety (Generalized Anxiety Disorder-7 (GAD-7 34 )), functioning (Work and Social Adjustment Scale (WSAS 35 )), health status (EuroQol 5 Dimension 5 Level (EQ-5D-5L 36 )) and drug use (Drug Abuse Screening Test-10 (DAST-10 37 ). ...
Article
Full-text available
Background Trauma plays an important role in the development of psychosis, but no studies have investigated whether a trauma-focused therapy could prevent psychosis. Aims This study aimed to establish whether it would be feasible to conduct a multicentre randomised controlled trial (RCT) to prevent psychosis in people with an at-risk mental state (ARMS), using eye-movement desensitisation and reprocessing therapy (EMDR). Method This started as a mixed-method randomised study comparing EMDR to treatment as usual but, as a result of low participant recruitment, was changed to a single-arm feasibility study. The proposed primary outcome for an RCT was transition to psychosis at 12-month follow-up. Data on secondary outcomes were also collected. Qualitative interviews were conducted with patients and therapists. Results Fourteen participants were recruited from the Early Intervention teams. Most people who expressed an interest in taking part attended an assessment to determine eligibility. All those eligible consented to take part. A total of 64% (7 of 11) of participants who were offered EMDR were followed up at 12 months. Of the 11 participants offered EMDR, one (11%, 95% CI: 0.2%, 48%) transitioned to psychosis. Nine patients and three therapists were interviewed. Participants who completed therapy ( n = 4; mean 10.5 sessions) found EMDR helpful, but those who discontinued ( n = 6; mean 5.2 sessions) said it had not benefitted them overall. Therapists said EMDR could be effective, although not for all patients. Conclusions Future studies recruiting people with an ARMS to an RCT may need to extend recruitment beyond Early Intervention teams. Although some individuals found EMDR helpful, reasons for discontinuing need to be addressed in future studies.
... A U.S. survey of practicing psychologists and psychiatrists found that the psychiatrists reported significantly more expertise than psychologists in tests assessing psychotic phenomena (Paulson et al., 2019). Of the three clinician-rated psychosis scales they listed (PSYRATS; Haddock et al., 1999;PANSS;Kay et al., 1987;BPRS;Overall & Gorham, 1988), 30% to 60% of clinical psychologists had never even heard of them. The fourth and last test they listed, the MMPI, was the only test with psychosis scales the psychologists knew. ...
Preprint
Full-text available
Conducting multimethod psychological assessments is a professional competency that uniquely distinguishes psychologists from other health providers. However, no overarching professional guidance exists as to what specific assessment methods to use for what specific purposes. This chapter serves as a basic primer to address that gap in the literature focusing primarily on psychosis as the exemplar. We use the Hierarchical Taxonomy of Psychopathology (HiTOP) as a framework from which to choose the key psychopathology dimensions: Emotional Dysfunction (Internalizing, Somatoform), Externalizing (Antagonistic, Disinhibited), and Psychosis (Thought Disorder, Detachment). Key assessment methods are the clinical interview using a collaborative phenomenological approach that includes the patient’s self-reported subjective experiences, follow-up interview, and behavioral observations; self-, informant-, and clinician-rating scales; cognitive and personality performance tests, both maximal and typical performance; records review; newly emerging technologies; and expert clinical judgment. The Internalizing dimension requires assessing the client’s internal subjective experience by self-report and self-reported behaviors outside the session. The Externalizing dimension focuses primarily on external sources to assess behavior, such as school and police records, and informant reports. The Psychosis dimension requires assessing the patient directly with clinical interview, exploration of the subjective experiences associated with psychosis, behavioral observations, standardized performance-based assessment, supplemented with informant-report, and all informed by clinical judgment as to whether the symptoms qualify as psychotic and whether a self-disorder exists. The last third of the chapter focuses primarily on the assessment of psychosis. We also describe current limitations of using HiTOP in clinical practice, such as the need to differentiate the etiologies of phenotypically similar symptoms. To be published in the Oxford Handbook of Personality and Psychopathology Assessment https://academic.oup.com/edited-volume/35425
... The psychotic symptom rating scales (PSYRATS) is a semistructured interview developed by Haddock et al. 23 This scale was designed to assess patients' experiences of both hallucinations and delusions. The section for auditory hallucinations (PSYRATS-AH) were used in the study. ...
Article
Objective: Auditory verbal hallucination (AVH) is a prominent symptom of schizophrenia causing profound distress. The influence of AVHs on insight appears to be intricate and contingent on other accompanying symptoms. This study investigated the relationship and possible mediators between AVHs and the degree of insight. Methods: One hundred patients with schizophrenia participated in the study. Scales were used to evaluate the hallucinatory experience, the level of insight and other psychopathology. Complex relationships between variables were envisaged as a path model, whose initial structure was constructed via Gaussian Graphical Model. The validity of the final model was verified by Structural Equation Modeling. Separate analyses were performed for self-reported and clinician-rated data to enhance the model's robustness. Results: The greater the severity of the physical aspects of AVHs, the lower the level of insight observed. Conversely, higher emotional distress was associated with increased insight. These relationships were only evident in the self-reported results and were not reflected in the clinician-rated results. The path model suggested that the Positive and Negative Syndrome Scale (PANSS) anxiety/depression factor was an important mediator that linked the found association. Notably, the PANSS negative symptom had the opposite effect on the PANSS anxiety/depression factor and insight, making it difficult to define its overall effect. Conclusion: The findings of this study provided one possible route for the positive influence of AVH experience in gaining insight. The mediating role of anxiety/depression modified by negative symptoms emerged as a valuable concept for clarifying this intricate relationship.
Article
Full-text available
Introduction Insomnia is a common symptom among patients with schizophrenia and schizoaffective disorder, negatively impacting symptom severity, functioning and well-being; however, it is rarely the direct focus of treatment. The main recommended treatment for insomnia is cognitive behavioural therapy (CBT-I). There is some evidence that CBT-I can also be used to treat insomnia in patients with schizophrenia, but only a few randomised controlled trials (RCTs) have been published. The aim of this ongoing RCT is to determine whether we can alleviate symptoms of insomnia and improve the quality of life in patients with schizophrenia and schizoaffective disorder through CBT-I delivered via the internet or in a group mode. Methods and analyses The aim of this study is to recruit 84–120 outpatients from the Psychosis Clinics of Helsinki University Hospital and the City of Helsinki Health Services. The main inclusion criteria are a diagnosis of schizophrenia or schizoaffective disorder and self-reported sleep problems. The study will be performed on a cyclic basis, with a target of 12–24 patients per cycle. Participants are randomly assigned into three groups: (1) a group receiving only treatment as usual (TAU), (2) internet-based individual therapy for insomnia (iCBT-I)+TAU or (3) group therapy for insomnia (GCBT-I) conducted via a virtual platform+TAU. The primary outcome measures are quantitative changes in the Insomnia Severity Index score and/or changes in health-related quality of life using the 15D quality of life measure. Secondary outcomes include self-reported variables for sleep, health, stress and the severity of psychotic and depressive symptoms; objective outcomes include actigraphy and bed sensor data to evaluate circadian rhythms and motor activity. Outcome measures are assessed at baseline and after the treatment period at weeks 12, 24 and 36. Ethics and dissemination The Coordinating Ethics Committee of the Hospital District of Helsinki and Uusimaa, Finland, approved the study protocol. The results will be published in peer-reviewed journals. Trial registration number NCT04144231.
Article
A BSTRACT Background Depressive disorders can present with psychotic features, which warrants a different diagnosis and a different phenomenological study. Aim To study the phenomenology of depressive disorders with and without psychotic features. Methodology One hundred and forty-eight patients presenting to psychiatry outpatient department of a tertiary care center were screened using Mini International Neuropsychiatric Interview questionnaire to select patients for our study. Sociodemographic data and some clinical variables of these patients were collected. These patients were further assessed for depression severity and psychotic symptoms by using Montgomery and Asberg Depression Rating Scale (MADRS) and Modified Psychotic Symptoms Ratings Scale (PSYRATS), respectively. Results Mean MADRS score for patients with depression without psychotic features was 38.38 and for patients with depression with psychotic features was 44.51. Result was found to be significant. Suicidality was found to be on a higher side in patients of depression with psychotic features. Conclusion Main finding related to our study was that depression severity was found to be more in patients of depression with psychotic features. There are certain phenomenological differences which warrant a separate diagnosis of depression with psychotic features. These include the increased intensity of suicidality, visible sadness, inner stress, difficulty in concentration, lassitude, altered ability to feel, and thoughts of suicide present in patients of depression with psychotic features.
Article
Full-text available
The characteristics of delusional experience were examined in a mixed group of 55 patients considered to be deluded; 11 belief characteristics were assessed by self-rating: conviction, preoccupation, interference, resistance, dismissibility, absurdity, self-evidentness, reassurance seeking, worry, unhappiness and pervasiveness. Only on level of conviction did no subject show a low score; on other dimensions there was considerable inter-subject variability. A principal components analysis indicated 4 components: distress, belief strength, obtrusiveness and concern. It is argued that delusions are most usefully regarded as multi-dimensional and, while characterised by conviction, vary considerably on other important dimensions.
Article
This book has been compiled for therapists who already have some experience in the clinical management of patients with psychiatric disorders, and its aim is to help them to start using cognitive-behavioural treatments in their clinical work. The first chapter describes the basic principles of psychology which are relevant to cognitive-behavioural treatments and outlines the development and principles of this type of therapy. The second chapter provides a detailed description of how to carry out a cognitive-behavioural assessment. . . . Within each of the succeeding chapters the authors have adopted a standard format, outlining the nature of each disorder and the development of current treatment approaches, and then providing a detailed practical account of how to carry out treatment. Particular attention is paid to dealing with difficulties encountered during treatment and reasons for treatment failure. The basic principle in all the chapters is that a treatment plan follows from a thorough cognitive-behavioural assessment and a formulation based on a psychological model of the specific disorder. It is not intended that the treatments described in this book should be viewed as standardized packages for particular conditions. Instead, the aim of each chapter is to provide the reader with sufficient information to carry out an assessment and plan individualized treatment for patients presenting with the wide range of problems seen in clinical practice. (PsycINFO Database Record (c) 2012 APA, all rights reserved)
Book
The abstract for this document is available on CSA Illumina.To view the Abstract, click the Abstract button above the document title.
Article
In clinical measurement comparison of a new measurement technique with an established one is often needed to see whether they agree sufficiently for the new to replace the old. Such investigations are often analysed inappropriately, notably by using correlation coefficients. The use of correlation is misleading. An alternative approach, based on graphical techniques and simple calculations, is described, together with the relation between this analysis and the assessment of repeatability.
Article
Simple 5-point scales are described together with the method used to study their reliability, the results of which are shown. The scales are short, easy to administer and sensitive to change, therefore particularly applicable where there is the need for screening chronic psychotic populations. Some uses for the scales are suggested.
Article
This paper reviews the most frequently used and misused reliability measures appearing in the mental health literature. We illustrate the various types of data sets on which reliability is assessed (i.e., two raters, more than two raters, and varying numbers of raters with dichotomous, polychotomous, and quantitative data). Reliability statistics appropriate for each data format are presented, and their pros and cons illustrated. Inadequancies of some methods are highlighted. The meaning of different levels of reliability obtained with various statistics is discussed. This critique is intended for the reading professional and the investigator who has an occasional need for reliability assessment. Statistical expertise is not required and theoretical material is referenced for the interested reader. Necessary formulas for computations are presented in the appendices. A summary table of some suitable reliability measures is presented.
Article
This review covers the design and analysis of essentially two types of reliability study: method comparison studies and generalizability (including inter-rater reliability) experiments. Likelihood-based methods of inference (confirmatory factor analysis and REML estimation of variance components, for example) are advocated, partly because of their ease of use but, primarily as a stimulus to the use of more ambitious designs for the investigation of the quality of measurements. The more sophisticated approaches are not intended to replace the simpler traditional methods, however, but are expected to be used to supplement them.
Article
A variation of procedure is described which greatly reduces the time required to administer Mulhall's PQRST. It lessens the sensitivity of the scale but retains other features. It uses the same materials as PQRST with some minor clerical alterations and, like the PQRST, takes less time to construct than Shapiro's original PQ. It has been used routinely with general practice and psychiatry out-patient referrals and is likely to have clinical rather than research application.
Article
Over 75 years ago, Bleuler (1911) confronted psychiatry with the question of ‘schizophrenia’ or ‘schizophrenias'. Today we recognise the heterogeneity of the condition, but we are still groping at efforts to clarify the different subtypes or subprocesses. Over the decades there have been various attempts to subclassify schizophrenia and tease apart the syndromes, none of which has been entirely successful. More recently, as a result of the work by Crow (1980) in England and Strauss et al (1974) in the USA, it has been proposed that two distinct syndromes can be discerned from the phenomenological profiles. The positive syndrome consists of productive features superadded to the mental status, such as delusions, hallucinations, and disorganised thinking. The negative syndrome represents absence of normal functions, such as deficits in the cognitive, affective, and social realms.